[1]
E. S. Sutrisnaningsih, S. Suharjono, and B. Sudarmanto, “ANALYSIS OF DEFERASIROX AND DEFERIPRON USE IN CHILDREN WITH PEDIATRIC -THALASSEMIA MAJOR”, FMI, vol. 52, no. 1, pp. 42–46, Mar. 2016.